Related Experiment Video
Updated: Jul 16, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
The effects of methylene blue on renal scarring due to pyelonephritis in rats
Burhan Aksu1, Mustafa Inan, Mehmet Kanter
1Department of Pediatric Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey. burhanfeyza@yahoo.com
Abstract:
The aim of this study was to evaluate the efficiency of methylene blue (MB) in preventing renal scar formation after the induction of pyelonephritis (PNP) in a rat model with delayed antimicrobial therapy. An inoculum of the K-12 strain of Escherichia coli was injected into both kidneys. Control groups received isotonic saline instead of bacterial solution. Four equal groups were then formed: the PNP group was untreated and the PNP ciprofloxacin (CIP) treated group was treated only with CIP intraperitoneally (i.p.) starting on the third day following bacterial inoculation. In the PNP (MB)-treated group, MB was given i.p., and in the PNP MB + CIP-treated group, MB + CIP were administered i.p.. In the sixth week following bacterial inoculation, all rats were sacrificed, and both kidneys of the rats in all groups were examined biochemically and histopathologically for renal scarring. Renal scar was significant in the groups treated with MB alone or MB + CIP combination compared with untreated or antibiotic only groups. Delayed treatment with antibiotics had no effect on scarring. These results suggest that the addition of MB to the delayed antibiotic therapy might be beneficial in preventing PNP-induced oxidative renal tissue damage.
Insights
Methylene blue (MB) may help prevent kidney scarring from pyelonephritis (PNP) when added to delayed antibiotic treatment. This combination showed reduced scarring compared to antibiotics alone in a rat model.
Area of Science:
- Nephrology
- Pharmacology
- Infectious Diseases
Background:
- Pyelonephritis (PNP) can lead to renal scarring, especially with delayed treatment.
- Oxidative damage contributes to tissue injury in PNP.
- Methylene blue (MB) has shown antioxidant properties.
Purpose of the Study:
- To assess the efficacy of methylene blue (MB) in preventing renal scarring post-pyelonephritis (PNP) in rats.
- To evaluate MB's role when combined with delayed antimicrobial therapy.
Main Methods:
- Induction of PNP in rats using Escherichia coli.
- Treatment groups: untreated, ciprofloxacin (CIP) alone, MB alone, and MB + CIP, all with delayed therapy initiation.
- Biochemical and histopathological examination of kidneys for renal scarring at six weeks.
Main Results:
- Significant reduction in renal scarring observed in groups treated with MB (alone or with CIP) compared to untreated or CIP-only groups.
- Delayed antibiotic therapy alone did not significantly impact scarring.
- MB addition to delayed antibiotic therapy showed potential benefits.
Conclusions:
- Methylene blue (MB) may be beneficial in preventing renal scarring associated with pyelonephritis (PNP).
- Combining MB with delayed antibiotic therapy could mitigate PNP-induced oxidative renal damage.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
